Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?

Salvatore Modica, Antonio Moschetta

Research output: Contribution to journalShort surveypeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds